Shilpa Medicare zooms 15% on compliance certificate from Japan

Shares of drug firm Shilpa Medicare soared by over 15 per cent today after the company received GMP compliance certificate from Japanese health regulator PMDA for its two active pharmaceutical ingredient (API) plants in Karnataka.
The stock zoomed 15.12 per cent to Rs 503.65 on BSE.
On NSE, it advanced by 14.9 per cent to Rs 503.80.
The company has received GMP compliance certificate from PMDA - Japan, for two API sites in Karnataka, Shilpa Medicare said in a BSE filing yesterday.
Established in 2004, Pharmaceuticals and Medical Devices Agency (PMDA) of Japan is tasked to protect the public health in Japan by assuring safety, efficacy and quality of pharmaceuticals and medical devices.

Meanwhile, in the broader market, the BSE Sensex was trading higher by 419.93 points at 25,565.52 at 1140 hrs.